Mirum Pharmaceuticals (MIRM) Operating Income: 2020-2025
Historic Operating Income for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Sep 2025 value amounting to $2.6 million.
- Mirum Pharmaceuticals' Operating Income rose 120.52% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$41.8 million, marking a year-over-year increase of 56.45%. This contributed to the annual value of -$87.6 million for FY2024, which is 19.74% up from last year.
- Mirum Pharmaceuticals' Operating Income amounted to $2.6 million in Q3 2025, which was up 152.17% from -$5.0 million recorded in Q2 2025.
- Over the past 5 years, Mirum Pharmaceuticals' Operating Income peaked at $2.6 million during Q3 2025, and registered a low of -$47.6 million during Q1 2021.
- Its 3-year average for Operating Income is -$19.5 million, with a median of -$24.2 million in 2024.
- Its Operating Income has fluctuated over the past 5 years, first tumbled by 116.11% in 2021, then soared by 120.52% in 2025.
- Quarterly analysis of 5 years shows Mirum Pharmaceuticals' Operating Income stood at -$45.6 million in 2021, then grew by 25.04% to -$34.2 million in 2022, then rose by 4.61% to -$32.6 million in 2023, then climbed by 25.67% to -$24.2 million in 2024, then surged by 120.52% to $2.6 million in 2025.
- Its Operating Income was $2.6 million in Q3 2025, compared to -$5.0 million in Q2 2025 and -$15.2 million in Q1 2025.